Key Points

Three brilliant scientists just won the 2025 Nobel Prize in Physiology or Medicine for their amazing work on immune tolerance. They figured out how our immune system knows not to attack our own body's tissues, which is crucial for preventing autoimmune diseases. This research is already helping develop better treatments for conditions like multiple sclerosis and type 1 diabetes. The international team includes two American researchers and one Japanese scientist who will share both the honor and the prize money.

Key Points: Brunkow Ramsdell Sakaguchi Win 2025 Nobel for Immune Tolerance

  • Trio discovered how the immune system distinguishes self from non-self tissues
  • Research helps prevent autoimmune diseases like multiple sclerosis and diabetes
  • Their work enables new treatments for immune-related disorders worldwide
  • Scientists from US and Japan share 11 million Swedish kronor prize equally
2 min read

Nobel Prize 2025 awarded to US and Japanese scientists for immune tolerance research

US and Japanese scientists awarded Nobel Prize for discovering how the immune system avoids attacking the body, paving the way for new autoimmune disease treatments.

"groundbreaking discoveries concerning peripheral immune tolerance - Nobel Assembly"

Washington, DC, October 6

Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their discoveries in peripheral immune tolerance -or in lay tems they discovered how the immune system is kept in check.

The announcement was made on Monday by the Nobel Assembly at the Karolinska Institutet in Stockholm, Sweden.

The trio--two based in the United States and one in Japan--was recognised for their "groundbreaking discoveries concerning peripheral immune tolerance." that prevents the immune system from harming the body.

This critical biological process helps the immune system distinguish between harmful invaders and the body's own tissues, preventing autoimmune diseases.

Their research has paved the way for advances in treating conditions such as multiple sclerosis, type 1 diabetes, and other immune-related disorders.

Born 1961 has a Ph.D. from Princeton University in the US. She is a senior Program Manager at the Institute for Systems Biology, in Seattle.

Fred Ramsdell, born 1960 has a PhD from the University of California, Los Angeles and is a scientific Advisor, Sonoma Biotherapeutics in San Francisco.

While Shimon Sakaguchi, born 1951 has a MD and Ph.D from Kyoto University in Japan.She is a Distinguished Professor at the Immunology Frontier Research Center, Osaka University, in Japan.

Prize amount: 11 million Swedish kronor, to be shared equally between the laureates, the Nobel Com.

Officially known as the Nobel Prize in Physiology or Medicine, the honour has been awarded 115 times to 229 Nobel Prize laureates between 1901 and 2024.

Last year's prize went to American scientists Victor Ambros and Gary Ruvkun, for their discovery of microRNA, tiny bits of genetic material that serve as on and off switches inside cells that help control what the cells do and when they do it.

The Nobel Peace Prize will be announced on Friday, and the Nobel Memorial Prize in economics next Monday.

The award ceremony will be held on December 10, the anniversary of the death of Alfred Nobel, a wealthy Swedish industrialist and the inventor of dynamite, who founded the prizes. He died in 1896.

- ANI

Share this article:

Reader Comments

R
Rohit P
Great achievement but I wish we had more Indian scientists in this field. Our research institutions need better funding and infrastructure to compete at this level. Still, congratulations to the winners!
A
Arjun K
Amazing work! Understanding immune tolerance could revolutionize treatment for type 1 diabetes which is becoming increasingly common in Indian children. Hope this research reaches clinical applications soon.
S
Sarah B
As someone with multiple sclerosis, this gives me so much hope! The immune system research is finally getting the recognition it deserves. Maybe one day we'll have better treatments available in India too.
V
Vikram M
International collaboration at its best! US and Japan working together shows how science transcends borders. We need more such partnerships with Indian researchers too.
M
Michael C
While this is excellent research, I'm concerned about how accessible these treatments will be for developing countries like India. Hope the patents don't make them unaffordable for our public healthcare system.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50